Skip to main content

Advertisement

ADVERTISEMENT

Poll

Practice Management: What Would You Like to Know?
Poll
03/02/2021
Submit your questions on practice management, from coding and billing to marketing and referrals, to guide our new initiatives with real-world examples and help move dermatology forward.
Submit your questions on practice management, from coding and billing to marketing and referrals, to guide our new initiatives with real-world examples and help move dermatology forward.
Submit your questions on...
03/02/2021
The Dermatologist
Poll
02/04/2021
Do you routinely screen for these diseases in your patients with HS? Let us know in the poll below!
Do you routinely screen for these diseases in your patients with HS? Let us know in the poll below!
Do you routinely screen for...
02/04/2021
The Dermatologist

Advertisement

Poll
02/03/2021
Survey: Tech in DermatologyWhether it's telederm, AI, or patient-reporting apps, what ways have you integrated technology into your practice? Share your thoughts below!Thank you for your input!Feel free to email...
Survey: Tech in DermatologyWhether it's telederm, AI, or patient-reporting apps, what ways have you integrated technology into your practice? Share your thoughts below!Thank you for your input!Feel free to email...
...
02/03/2021
The Dermatologist
Poll
01/19/2021
Which staging system for risk stratification of cutaneous malignancies does your practice use? Let us know in this poll!
Which staging system for risk stratification of cutaneous malignancies does your practice use? Let us know in this poll!
Which staging system for risk...
01/19/2021
The Dermatologist
Poll
10/30/2020
Do you consider mental health in the treatment plan for your patients with psoriasis? Let us know in the poll below!
Do you consider mental health in the treatment plan for your patients with psoriasis? Let us know in the poll below!
Do you consider mental health in...
10/30/2020
The Dermatologist

Advertisement

Poll
09/28/2020
The Dermatologist is s planning its 2021 editorial calendar, and we want to hear from you. When it comes to aesthetics, what topics would you like to see us cover? Let us know in the poll below!
The Dermatologist is s planning its 2021 editorial calendar, and we want to hear from you. When it comes to aesthetics, what topics would you like to see us cover? Let us know in the poll below!
The Dermatologist is s planning...
09/28/2020
The Dermatologist
Poll
09/15/2020
A recent meta-analysis reviewed the latest evidence on efficacy and tolerability of the available biologic agents for the treatment of moderate to severe plaque psoriasis. Do you agree with their results? Let us know!
A recent meta-analysis reviewed the latest evidence on efficacy and tolerability of the available biologic agents for the treatment of moderate to severe plaque psoriasis. Do you agree with their results? Let us know!
A recent meta-analysis reviewed...
09/15/2020
The Dermatologist
Poll
08/13/2020
In this edition of You Make the Call, your patient presents with worsening plaque psoriasis (>8% BSA) now affecting his scalp and bilateral upper extremities after failing effective treatment with narrowband UV-B and topical corticosteroid...
In this edition of You Make the Call, your patient presents with worsening plaque psoriasis (>8% BSA) now affecting his scalp and bilateral upper extremities after failing effective treatment with narrowband UV-B and topical corticosteroid...
In this edition of You Make the...
08/13/2020
The Dermatologist

Advertisement

Poll
08/05/2020
The decision to start a patient with psoriasis onto a systemic agent for disease management is an important conversation between provider and patient. When considering a biologic for the treatment of plaque psoriasis, what is the most...
The decision to start a patient with psoriasis onto a systemic agent for disease management is an important conversation between provider and patient. When considering a biologic for the treatment of plaque psoriasis, what is the most...
The decision to start a patient...
08/05/2020
The Dermatologist

Advertisement